Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neural Interoceptive Processing is Modulated by Deep Brain Stimulation for Treatment Resistant Depression.
Xu E, Pitts S, Dahill-Fuchel J, Scherrer S, Nauvel T, Overton JG, Riva-Posse P, Crowell A, Figee M, Alagapan S, Rozell C, Choi KS, Mayberg HS, Waters AC. Xu E, et al. bioRxiv [Preprint]. 2023 Dec 20:2023.12.15.571885. doi: 10.1101/2023.12.15.571885. bioRxiv. 2023. Update in: Biol Psychiatry Cogn Neurosci Neuroimaging. 2024 Nov 30:S2451-9022(24)00358-6. doi: 10.1016/j.bpsc.2024.11.021 PMID: 38187733 Free PMC article. Updated. Preprint.
Mapping depression rating scale phenotypes onto research domain criteria (RDoC) to inform biological research in mood disorders.
Ahmed AT, Frye MA, Rush AJ, Biernacka JM, Craighead WE, McDonald WM, Bobo WV, Riva-Posse P, Tye SJ, Mayberg HS, Hall-Flavin DK, Skime MK, Jenkins GD, Wang L, Krishnan RR, Weinshilboum RM, Kaddurah-Daouk R, Dunlop BW; Mood Disorders Precision Medicine Consortium (MDPMC). Ahmed AT, et al. J Affect Disord. 2018 Oct 1;238:1-7. doi: 10.1016/j.jad.2018.05.005. Epub 2018 May 26. J Affect Disord. 2018. PMID: 29807322 Free PMC article.
Acylcarnitine metabolomic profiles inform clinically-defined major depressive phenotypes.
Ahmed AT, MahmoudianDehkordi S, Bhattacharyya S, Arnold M, Liu D, Neavin D, Moseley MA, Thompson JW, Williams LSJ, Louie G, Skime MK, Wang L, Riva-Posse P, McDonald WM, Bobo WV, Craighead WE, Krishnan R, Weinshilboum RM, Dunlop BW, Millington DS, Rush AJ, Frye MA, Kaddurah-Daouk R; Mood Disorders Precision Medicine Consortium (MDPMC). Ahmed AT, et al. J Affect Disord. 2020 Mar 1;264:90-97. doi: 10.1016/j.jad.2019.11.122. Epub 2019 Nov 30. J Affect Disord. 2020. PMID: 32056779 Free PMC article.
Development of the Ketamine Side Effect Tool (KSET).
Short B, Dong V, Gálvez V, Vulovic V, Martin D, Bayes AJ, Zarate CA, Murrough JW, McLoughlin DM, Riva-Posse P, Schoevers R, Fraguas R, Glue P, Fam J, McShane R, Loo CK. Short B, et al. J Affect Disord. 2020 Apr 1;266:615-620. doi: 10.1016/j.jad.2020.01.120. Epub 2020 Jan 25. J Affect Disord. 2020. PMID: 32056935 Free PMC article.
ElectroConvulsive therapy Cognitive Assessment (ECCA) tool: A new instrument to monitor cognitive function in patients undergoing ECT.
Hermida AP, Goldstein FC, Loring DW, McClintock SM, Weiner RD, Reti IM, Janjua AU, Ye Z, Peng L, Tang YL, Galendez GC, Husain MM, Maixner DF, Riva-Posse P, McDonald WM; National Network of Depression Centers ECT Task Group. Hermida AP, et al. J Affect Disord. 2020 May 15;269:36-42. doi: 10.1016/j.jad.2020.03.010. Epub 2020 Mar 4. J Affect Disord. 2020. PMID: 32217341
62 results